LACK OF PHARMACOKINETIC INTERACTIONS BETWEEN MOXONIDINE AND DIGOXIN

被引：6
|
作者：
PABST, G
WEIMANN, HJ
WEBER, W
机构：
[1] KALI CHEM PHARMA GMBH, POB 220, W-3000 HANNOVER 1, GERMANY
[2] LAB GMBH & CO, NEU ULM, GERMANY
来源：
CLINICAL PHARMACOKINETICS | 1992年 / 23卷 / 06期
关键词：
D O I：
10.2165/00003088-199223060-00007
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The potential for pharmacokinetic interactions between moxonidine and digoxin at steady-state was investigated in 15 healthy male volunteers. Multiple oral doses of 0.2mg moxonidine twice daily and 0.2mg digoxin once daily were administered alone and in combination in a randomised 3-period crossover design. The drugs were administered for at least 5 days. The results indicate that neither moxonidine nor digoxin influences the pharmacokinetics of the other drug under steady-state conditions.
引用
收藏
页码：477 / 481
页数：5
相关论文
共 50 条
  • [1] LACK OF PHARMACOKINETIC INTERACTION BETWEEN MOXONIDINE AND HYDROCHLOROTHIAZIDE
    WEIMANN, HJ
    PABST, G
    WEBER, W
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (02) : 209 - 210
  • [2] Lack of Pharmacokinetic Interactions Between Dapagliflozin and Simvastatin, Valsartan, Warfarin, or Digoxin
    Sreeneeranj Kasichayanula
    Ming Chang
    Xiaoni Liu
    Wen-Chyi Shyu
    Steven C. Griffen
    Frank P. LaCreta
    David W. Boulton
    Advances in Therapy, 2012, 29 : 163 - 177
  • [3] Lack of Pharmacokinetic Interactions Between Dapagliflozin and Simvastatin, Valsartan, Warfarin, or Digoxin
    Kasichayanula, Sreeneeranj
    Chang, Ming
    Liu, Xiaoni
    Shyu, Wen-Chyi
    Griffen, Steven C.
    LaCreta, Frank P.
    Boulton, David W.
    ADVANCES IN THERAPY, 2012, 29 (02) : 163 - 177
  • [4] Indiplon and warfarin, theophylline and digoxin: Lack of pharmacokinetic interactions
    Abel, B
    Hershberger, E
    Corrigan, B
    Bozigian, H
    Madan, A
    Chen, TK
    Gately, N
    Boyd, M
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (09): : 1077 - 1077
  • [5] Lack of a pharmacokinetic interaction between milnacipran and digoxin.
    Periclou, A.
    Palmer, R. H.
    Shi, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S22 - S23
  • [6] PHARMACODYNAMIC AND PHARMACOKINETIC INTERACTIONS BETWEEN DIGOXIN AND BEPRIDIL
    BELZ, CG
    WISTUBA, S
    STERN, HC
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (02) : 181 - 181
  • [7] PHARMACOKINETIC INTERACTIONS BETWEEN DIGOXIN AND OTHER DRUGS
    MARCUS, FI
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 5 (05) : A82 - A90
  • [8] PHARMACOKINETIC INTERACTIONS WITH DIGOXIN
    RODIN, SM
    JOHNSON, BF
    CLINICAL PHARMACOKINETICS, 1988, 15 (04) : 227 - 244
  • [9] SOME PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS BETWEEN DIGOXIN AND GENTAMICIN
    STANEVASTOYTCHEVA, D
    KRISTEVA, E
    PRODANOVA, K
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1992, 17 (01) : 1 - 8
  • [10] Lack of pharmacokinetic interaction between gemifloxacin and digoxin in healthy elderly volunteers
    Vousden, M
    Allen, A
    Lewis, A
    Ehren, N
    CHEMOTHERAPY, 1999, 45 (06) : 485 - 490
12345